The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment
Open accessAbstract
Objective: ADHD, or Attention-Deficit/Hyperactivity Disorder, is a neurodevelopmental disorder that is known for its high degree of heterogeneity. It often coexists with other psychiatric diseases, especially anxiety and depression. This article reviews recent studies to explore the etiology of comorbid anxiety and depressive disorders in adults with ADHD, analyzing the factors contributing to this elevated comorbidity rate from several perspectives. Additionally, we explore potential directions for future research in this field. Recent findings: ADHD exhibits a high comorbidity rate with anxiety and depressive disorders, due to overlapping and interacting symptoms. Individuals with two or more comorbid conditions often experience increased disease burden, prolonged illness duration, and diminished treatment efficacy. The underlying causes of comorbid anxiety and depression in ADHD patients are highly complex and can be understood from multiple dimensions, including genetics, neurobiology, neurocognition, and neuroimaging. This complexity poses significant challenges for clinical diagnosis and treatment. Currently, the management of ADHD patients with concurrent depression or anxiety may involve pharmaceutical interventions combined with non-pharmacological strategies, including psychotherapy (e.g., cognitive-behavioral therapy, CBT) and digital therapeutics. For patients with comorbid illnesses, these intergrated approaches have demonstrated significant improvements in symptom relief and quality of life enhancement. Summary: ADHD is a highly heterogeneous disorder with a significant comorbidity rate. Recent research has elucidated the pathogenetic mechanisms of ADHD comorbid with depression and anxiety disorders from multiple perspectives. To improve patient functioning, enhance their quality of life, and guide more effective treatments, Further studies are needed to investigate the underlying causes of these comorbid conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Epidemiological studies consistently show high psychiatric comorbidity, with 50–80% of adults meeting criteria for at least one additional mental disorder [106,107].”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [106]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mood and anxiety disorders represent the most common comorbidities, affecting ~50% and 20–50% of adults with ADHD, respectively [106].”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [106]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depressive and anxiety symptoms are typically episodic, often fluctuating with life stressors, whereas attentional deficits in ADHD are chronic, pervasive, and present across developmental stages [106,107].”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [106]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“many individuals treated exclusively for depression or anxiety continue to experience disabling attentional symptoms, delaying recovery [106,112]”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [106]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Comorbidity substantially worsens clinical course, functioning, and safety outcomes, including hospitalization, legal problems, and suicide risk [106].”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
Molecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357
Kaiser, R. H., Andrews-Hanna, J. R., Wager, T. D., & Pizzagalli, D. A. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0071 · Cited by 2,281
Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis
Thomas, R., Sanders, S., Doust, J., Beller, E., & Glasziou, P. (2015) · Pediatrics · doi:10.1542/peds.2014-3482 · Cited by 1,976
Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation
Shaw, P., Eckstrand, K., Sharp, W., Blumenthal, J., Lerch, J. P., Greenstein, D., Clasen, L., Evans, A., Giedd, J., & Rapoport, J. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707741104 · Cited by 1,819
Architectonic subdivision of the human orbital and medial prefrontal cortex
Öngür, D., Ferry, A. T., & Price, J. L. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10609 · Cited by 944
Song, P., Zha, M., Yang, Q., Zhang, Y., Li, X., & Rudan, I. (2021) · Journal of Global Health · doi:10.7189/jogh.11.04009 · Cited by 896 · cited 2×
“Prevalence rates for both subtypes exhibited age-dependent declines, while the persistent subtype demonstrated higher prevalence in low-and middle-income countries (LMICs) (6).”
InfluentialLarge-scale brain systems in ADHD: beyond the prefrontal–striatal model
Castellanos, F. X., & Proal, E. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.11.007 · Cited by 831 · cited 1×
“They also demonstrate hyperactivation of the occipital lobe during tasks requiring inhibition, working memory, and attention (56).”
Collaborators, O. B. O. T. W. W. M. H. S., Fayyad, J., Sampson, N. A., Hwang, I., Adamowski, T., Aguilar-Gaxiola, S., Al-Hamzawi, A., Andrade, L. H. S. G., Borges, G., de Girolamo, G., et al. (2017) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-016-0208-3 · Cited by 824 · cited 1×
“Epidemiological evidence suggests that approximately 50 – 70% of childhood-onset cases persist into adulthood, whereas the prevalence in adults is estimated at 2 – 3%, based on population studies (2).”
The neural correlates of attention deficit hyperactivity disorder: an ALE meta‐analysis
Dickstein, S. G., Bannon, K., Xavier Castellanos, F., & Milham, M. P. (2006) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2006.01671.x · Cited by 745
Cited by
ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives
Bogdańska-Chomczyk, E., Majewski, M. K., & Kozłowska, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211020 · Cited by 15
“Notably, many individuals treated exclusively for depression or anxiety continue to experience disabling attentional symptoms, delaying recovery [106,112].”
InfluentialThe Cerebellar Neuropsychiatric Rating Scale Version 2: Development and Validation
Selvadurai, L. P., Burt, A. L., Daly, M. P., Sherman, J. C., & Schmahmann, J. D. (2025) · The Cerebellum · doi:10.1007/s12311-025-01930-y · Cited by 5
The spectrum of neurodevelopmental disorders: comorbidities as clues to pathogenesis
McHugh, C. M., John, J. R., Wu, W. T., & Eapen, V. (2026) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000001068 · Cited by 4
Self-citationExplaining heterogeneity: Latent profiles of adult attention-deficit/hyperactivity disorder
McGuigan, L. M., Simons, M. U., Mengwasser, S. T., Marshall, P., & Hoelzle, J. B. (2025) · Applied Neuropsychology Adult · doi:10.1080/23279095.2025.2568595 · Cited by 3
de Melo, I. H., & França, G. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1813029 · Cited by 4
“The persistent frustration, chronic self-criticism, feelings of inadequacy, and emotional exhaustion associated with unrecognized and untreated ADHD can generate a depressive-like affective state that mimics core symptoms of depression (21).”
Metadata
- Authors
- Fu, X., Wu, W., Wu, Y., Liu, X., Liang, W., Wu, R., & Li, Y.
- Affiliations
- Fujian Medical University (CN)
- Corresponding author
- Li, Yun
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2025-06-06
- Volume
- 16
- Pages
- 1597559-1597559
- ISSN
- 1664-0640 (ISSN-L)
- PMC
- PMC12179154
- OpenAlex
- W4411107682
- Cited by
- 54
- References
- 95
- Citations by year
- 2026: 44 · 2025: 10
- FWCI
- 9.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- adult ADHD, comorbidities, anxiety disorders, depressive disorders, etiology, treatment, cognitive behavioral therapy, digital therapeutics, pharmacotherapy, neurobiology, genetic factors, neuroimaging, neurocognitive function, quality of life
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment. https://app.cochat.ai/papers/10.3389/fpsyt.2025.1597559
- The paper
- Fu, X., Wu, W., Wu, Y., Liu, X., Liang, W., Wu, R., & Li, Y. (2025). Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2025.1597559
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.